Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Panza

Showing results (51-60 of 71) with videos related to

Pageof 8
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 28, 2002
Phase I/II study of paclitaxel, gemcitabine and vinorelbine as first-line chemotherapy of non-small-cell lung cancerV Lorusso, E Crucitta, N Panza, et al.
Clinical Endocrinology|July 1, 1997
Increased prevalence of colonic polyps and altered lymphocyte subset pattern in the colonic lamina propria in acromegalyA Colao, A Balzano, D Ferone, et al.
Journal of Endocrinological Investigation|December 1, 1992
Hormonal and immunological pattern in a patient with acquired immunodeficiency syndrome related complex and Cushing's syndromeR Rossi, A P Tommaselli, N Panza, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 24, 1997
Cisplatin, gemcitabine and vinorelbine in locally advanced or metastatic non-small-cell lung cancer: a phase I studyG Frasci, N Panza, P Comella, et al.
Nuclear Medicine Communications|May 1, 1988
A prospective imaging study of 131I-B72.3 monoclonal antibody in patients with epithelial ovarian cancer: preliminary reportS Lastoria, P D'Amico, L Mansi, et al.
British Journal of Cancer|July 22, 2004
Gemcitabine with either paclitaxel or vinorelbine vs paclitaxel or gemcitabine alone for elderly or unfit advanced non-small-cell lung cancer patientsP Comella, G Frasci, P Carnicelli, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1994
CV 205-502 in the treatment of tumoral and non-tumoral hyperprolactinemic statesB Merola, F Sarnacchiaro, A Colao, et al.
The Journal of Clinical Endocrinology and Metabolism|March 20, 1998
Bone marker and bone density responses to dopamine agonist therapy in hyperprolactinemic malesC Di Somma, A Colao, A Di Sarno, et al.
Lung Cancer (Amsterdam, Netherlands)|August 1, 1996
Partial substitution of cisplatin with carboplatin in combination with etoposide in advanced non-small cell lung cancer (NSCLC): a multicentric randomised phase II trialP Comella, G Frasci, N Panza, et al.
British Journal of Cancer|May 5, 2001
A weekly regimen of cisplatin, paclitaxel and topotecan with granulocyte-colony stimulating factor support for patients with extensive disease small cell lung cancer: a phase II studyG Frasci, G Nicolella, P Comella, et al.
Pageof 8

Showing results (51-60 of 71) with videos related to

Sort By:
Pageof 8
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 28, 2002
Phase I/II study of paclitaxel, gemcitabine and vinorelbine as first-line chemotherapy of non-small-cell lung cancerV Lorusso, E Crucitta, N Panza, et al.
Clinical Endocrinology|July 1, 1997
Increased prevalence of colonic polyps and altered lymphocyte subset pattern in the colonic lamina propria in acromegalyA Colao, A Balzano, D Ferone, et al.
Journal of Endocrinological Investigation|December 1, 1992
Hormonal and immunological pattern in a patient with acquired immunodeficiency syndrome related complex and Cushing's syndromeR Rossi, A P Tommaselli, N Panza, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 24, 1997
Cisplatin, gemcitabine and vinorelbine in locally advanced or metastatic non-small-cell lung cancer: a phase I studyG Frasci, N Panza, P Comella, et al.
Nuclear Medicine Communications|May 1, 1988
A prospective imaging study of 131I-B72.3 monoclonal antibody in patients with epithelial ovarian cancer: preliminary reportS Lastoria, P D'Amico, L Mansi, et al.
British Journal of Cancer|July 22, 2004
Gemcitabine with either paclitaxel or vinorelbine vs paclitaxel or gemcitabine alone for elderly or unfit advanced non-small-cell lung cancer patientsP Comella, G Frasci, P Carnicelli, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1994
CV 205-502 in the treatment of tumoral and non-tumoral hyperprolactinemic statesB Merola, F Sarnacchiaro, A Colao, et al.
The Journal of Clinical Endocrinology and Metabolism|March 20, 1998
Bone marker and bone density responses to dopamine agonist therapy in hyperprolactinemic malesC Di Somma, A Colao, A Di Sarno, et al.
Lung Cancer (Amsterdam, Netherlands)|August 1, 1996
Partial substitution of cisplatin with carboplatin in combination with etoposide in advanced non-small cell lung cancer (NSCLC): a multicentric randomised phase II trialP Comella, G Frasci, N Panza, et al.
British Journal of Cancer|May 5, 2001
A weekly regimen of cisplatin, paclitaxel and topotecan with granulocyte-colony stimulating factor support for patients with extensive disease small cell lung cancer: a phase II studyG Frasci, G Nicolella, P Comella, et al.
Pageof 8